Our vision
We choose a 'Value Based Healthcare' approach, where we organize ourselves into an Integrated Practice Unit around the clinical entity of psoriasis, coined PsoPlus®. Inherent to this approach, we keep track of patient-relevant outcome measures (whether or not in official registries). At the same time we investigate and optimize the costs we have to make to achieve these outcomes.
As we want to raise value for our patients, we are fueling continuous improvement through further research activities: by optimizing the appropriate use of the immunological treatments through therapeutic drug monitoring, by looking for new pathogenic insights, and prediction marker research, but also by looking into the effect of novel interventions such as diet. We also have established a gene cream proof of concept in an organoid psoriasis model. These novel research insights are coupled back into the patient approach in PsoPlus®.
